102 results
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
Share Exchange Agreement under which it exchanged 1,070,000 ordinary shares of the Company for the remaining minority interest of 21.68% of iOx. See … and SalvaRx entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with each of the minority shareholders of iOx (the “Sellers”) resulting
6-K
EX-99.1
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
minority interest of 21.68% of iOx. See Note 17, “Related Party Transactions – Share Exchange Agreement – iOx,” for a further discussion.
On July 6, 2022 … 18, 2022, the Company and SalvaRx entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with each of the minority shareholders
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
Agreement”) with each of the minority shareholders of iOx (the “Sellers”) resulting in the acquisition of the outstanding non-controlling ownership interest
424B3
PRTG
Portage Biotech Inc
28 Nov 23
Prospectus supplement
4:03pm
for the remaining minority interest of 21.68% of iOx. See Note 16, “Related Party Transactions – Share Exchange Agreement – iOx,” for a further discussion … Agreement”) with each of the minority shareholders of iOx (the “Sellers”) resulting in the acquisition of the outstanding non-controlling ownership
6-K
EX-99.1
PRTG
Portage Biotech Inc
28 Nov 23
Current report (foreign)
4:01pm
Agreement under which it exchanged 1,070,000 ordinary shares of the Company for the remaining minority interest of 21.68% of iOx. See Note 16, “Related Party … and SalvaRx entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with each of the minority shareholders of iOx (the “Sellers
6-K
EX-99.2
orvq646rapleuj0ek9
28 Nov 23
Current report (foreign)
4:01pm
424B3
pnuadfk
7 Nov 23
Prospectus supplement
4:50pm
F-1
fbrvl3bar8f
31 Oct 23
Registration statement (foreign)
4:05pm
424B5
mthxyiqe3olp96q79
2 Oct 23
Prospectus supplement for primary offering
6:01pm
6-K
EX-99.2
a1237z
29 Aug 23
Current report (foreign)
4:01pm
6-K
EX-99.1
aocmd 7gjlzj
29 Aug 23
Current report (foreign)
4:01pm
6-K
EX-99.1
gfhev rixdkki2896
29 Nov 22
Current report (foreign)
4:58pm
6-K
EX-99.2
imn8e7f 69q
29 Nov 22
Current report (foreign)
4:58pm
6-K
EX-99.1
eijw8lk15v9g
29 Aug 22
Current report (foreign)
4:00pm
424B5
hz4952x9w8st
19 Aug 22
Prospectus supplement for primary offering
10:52am
6-K
EX-99.1
sa6cy5ak5a30fmr e4wt
1 Aug 22
Current report (foreign)
4:48pm